The MHC dass II-associated invariant chain (Ii) is involved in the intracdlular sorting of class II molecules to the endocytic pathway where peptides from processed exogenous antigens are bound, and thereby Ii is thought to enhance antigen presentation. Here we demonstrate that presentation of only one out of five epitopes of a given antigen is augmented by Ii. We have compared the presentation of five different epitopes derived from hen egg white lysozyme (HEL) to Ak-restricted T hybridomas by rat-2 fibroblasts transfected with A~ k and A~' (RKK) and RKK cells supertransfected with the mouse invariant chain (RKKI). Only the presentation of the HEL epitope 46-61 was enhanced whereas the presentation of the HEL epitopes 25-43, 34-45, 112-124, and 116-129 was unchanged or even slightly diminished in RKKI cells. The presentation of the epitopes 25-43 and 34-45 was virtually insensitive to the lysosomotropic reagent chloroquine. Brefeldin A (BFA), which inhibits protein egress from the endoplasmic reticulum, blocked the presentation of all epitopes tested in RKKI cells. In contrast, in Ii-negative RKK cells only the presentation of the epitope HEL(46-61) was inhibited by BFA and the presentation of the epitopes 25-43 and 34-45 was only slightly impaired. These findings suggest that Ii may target class II molecules to selected endosomal subcompartments involved in the processing of different peptides derived from an endocytosed antigen. As a result, the enhancement of the class II-restricted presentation in Ii expressing cells appears to be epitope specific rather than antigen specific.
Summary
The MHC dass II-associated invariant chain (Ii) is involved in the intracdlular sorting of class II molecules to the endocytic pathway where peptides from processed exogenous antigens are bound, and thereby Ii is thought to enhance antigen presentation. Here we demonstrate that presentation of only one out of five epitopes of a given antigen is augmented by Ii. We have compared the presentation of five different epitopes derived from hen egg white lysozyme (HEL) to Ak-restricted T hybridomas by rat-2 fibroblasts transfected with A~ k and A~' (RKK) and RKK cells supertransfected with the mouse invariant chain (RKKI). Only the presentation of the HEL epitope 46-61 was enhanced whereas the presentation of the HEL epitopes 25-43, 34-45, 112-124, and 116-129 was unchanged or even slightly diminished in RKKI cells. The presentation of the epitopes 25-43 and 34-45 was virtually insensitive to the lysosomotropic reagent chloroquine. Brefeldin A (BFA), which inhibits protein egress from the endoplasmic reticulum, blocked the presentation of all epitopes tested in RKKI cells. In contrast, in Ii-negative RKK cells only the presentation of the epitope HEL(46-61) was inhibited by BFA and the presentation of the epitopes 25-43 and 34-45 was only slightly impaired. These findings suggest that Ii may target class II molecules to selected endosomal subcompartments involved in the processing of different peptides derived from an endocytosed antigen. As a result, the enhancement of the class II-restricted presentation in Ii expressing cells appears to be epitope specific rather than antigen specific.
eT~he MHC class II-associated invariant chain has been .L ascribed a number of different functions. One proposed role is to provide a sorting signal for the intracellular transport ofdass II molecules (1) . In HeLa ceils, transport of class II molecules to the endocytic compartment was observed only when Ii was coexpressed (2, 3) . Ii probably directs dass II molecules to a late endosomal compartment (4) . A second role has been suggested by biochemical studies indicating that Ii can block the peptide binding to dass II o~ dimers (5, 6) . Thus, Ii may prevent peptide loading onto class II molecules in preendosomal compartments. A third possible role of Ii is to act as a chaperone in the assembly and folding of dass II molecules, and in their egress from the endoplasmic reticulum (7, 8) .
These proposed functions suggest that Ii may facilitate the class II-restricted presentation of exogenous antigens to T cells. For Ltk-cells transfected with mouse class II genes in the presence or absence of Ii, Ii expression was reported to enhance the presentation of some antigens like the complement component C5 (9), hen egg lysozyme or measles virus hemagglutinin (10), but not of other antigens like ovalbumin or pork insulin (11) . The crucial role of Ii in the presentation of certain antigens was further demonstrated with splenocytes from mice lacking the Ii gene (12) . Recently, it was shown that the alternatively spliced Ii gene product p41 plays a role in the enhanced presentation of some antigens (13) . Utilizing rat-2 fibroblasts expressing A k in the presence or absence of Ii, we previously reported that presentation of HEL but not of ribonuclease A (RNase) was enhanced in the presence ofli (14) . Extending these findings we now show that the facilitating function of Ii is restricted to only one out of five epitopes derived from processing of HEL, suggesting that Ii may be involved in the fine tuning of the immune response to exogenous antigens.
Materials and Methods
Transfectants. Rat-2 fibroblasts transfected with cDNA con-structs coding for the o~ and B chain of A k (RKK) have been described (14) . Supertransfection with genomic DNA coding for mufine Ii was performed as described (14) . RKKI done 4 which expresses high amounts of Ii was used in this study. Cell Cultures. Antigen presentation assays were performed as described (13, 14) . Briefly, cultures containing 2. RKK and RKKI cells were preincubated with graded doses of chloroquine (Sigma Chemical Co.) for 30 min or with brefeldin A (BFA) (Sandoz) for 15 min in complete medium followed by the addition of antigen for 4 h as described (19) . Subsequently, the ceils were fixed in 0.05% glutaraldehyde for 30 s on ice, quenched in 0.2 M glycine, and washed three times before T hybridoma cells were added.
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Results and Discussion
The influence of Ii on the presentation of helper epitopes derived from HEL was studied using Ak-transfected Iinegative rat-2 fibroblasts (RKK), or R K K ceils supertransfected with genomic D N A coding for mouse Ii (RKKI). In RKKI cells a high level of Ii expression in excess of A k molecuhs was shown by sequential immunoprecipitation with monodonal antibodies against A k and Ii (Fig. 1 a) . The expression of Ii in RKKI ceUs was homogenous as determined by intraceilular cytofluorometry (Fig. 1 b) . The level of A k cell surface expression was slightly lower in the RKKI done used in this study than in R K K parental cells (Fig. 1 b) , possibly due to intrinsic clonal variability of these ceils. Although Ii is supposed to facilitate the egress of class II molecules from the endoplasmic reticulum we have observed similar levels of surface class II on a large variety of class II transfectants such as rat-2, HeLa, and RMA cells in the absence and presence of Ii. This is in contrast to splenocytes from Ii knockout mice, which express only low levels of class II on the cell surface (12) . The reason for this discrepancy is not clear. In any case, when differences in I-A k expression were taken into account, the relative ability of surface class II molecules to bind peptides was similar in RKK and RKKI cells (Fig. 1 c) . 10 T ceU hybridomas with specificity for five Ak-restricted HEL epitopes were used to study the effect of Ii on the presentation of individual epitopes. In Table 1 , a quantitative evaluation of the response curves is given. The ratio of the antigen concentrations yidding 50% of the maximal responses (ECs0) for RICK vs. RKKI cells was greater than 3.0 for all five T cell hybridomas recognizing the HEL peptide 46-61, namely 1C5.1, 4G4.1, 1G5.1, 2B5.1, and 3A9, indicating a dear enhancement of the presentation of this epitope in the presence of Ii. A typical example is presented in Fig. 2 a. It can be seen that RKKI cells stimulated 3A9 T hybridoma (Table 1) . Exogenously added peptide was always presented somewhat more ei~ciently by RKK cells than by RKKI cells. This difference probably reflects the slightly higher level of A k expression in RKK because the degree of loading with peptide was similar for both cell lines (Fig. 1 c) . The fine specificities of these hybridomas for shorter peptides within the sequence 46-61 have not been compared. Thus, it seems possible that the differences in the ECs0 ratios are due to differentially enhanced presentation of subdeterminants of epitope 46-61.
Using the hybridomas 2B6.31 (Fig. 2 b) and 3Bl1.1 recognizing the overlapping HEL epitopes 25-43 and 34-45, respectively, an ECs0 ratio dose to unity was found indicating that Ii did not facilitate the presentation of these epitopes. The hybridomas 2I)4.1, 2C8.4, and 1139.1 recognizing the overlapping COOH-terminal epitopes HEL 112-124 and 116-129 , respectively, showed ECs0 ratios <1.0 demonstrating the lack of enhancement for these epitopes by Ii. For comparison, the hybridoma TS1.2 specific for the gNase epitope 43-56 was included (Table 1) hybridomas we studied the effect of chloroquine on the presentation of HEL epitopes by RKK and RKKI cells (Fig.  3) . Interestingly, the presentation of the epitope 34-45 was not inhibited by titrated doses of chloroquine in RKK cells, and showed a slight inhibition only at 300 gM in RKKI cells. Similarly, increasing doses of chloroquine had little effect on the presentation of epitope 25-43. In contrast, chloroquine clearly inhibited the presentation of the epitopes 46-61 and 116-129 in both RKK and RKKI cells. For the four epitopes studied, presentation by RKKI cells was always somewhat more sensitive to chloroquine than presentation by RKK cells (see Fig. 3 b) . This is in agreement with the observation that chloroquine inhibits the proteolytic removal of Ii from dass II oe3 dimers before their transport to the cell surface (21) . The fungal metabolite brefeldin A blocks the vesicular transport from the endoplasmic reticulum. In addition, BFA was reported to induce the fusion of early endosomes with the trans-Golr~ network (22) . However, the extent of impairment induced by BFA on the transport and the degradation of endocytosed proteins is controversial (22, 23) . We have studied the effect of BFA on the presentation of the HEL epitopes 25-43, 34-45, and 46-61 (Fig. 4) . When RKK cells were used as APC, the presentation of the epitopes 25-43 and 34-45 was inhibited by only 30-40% even at the highest BFA doses used, whereas the presentation of epitope 46-61 was almost completely blocked. In a previous study presentation of epitope 116-129 by LK-35.2 B cells was also inhibited by BFA (24) . In RKKI cells, the presentation of the three epitopes tested was clearly inhibited by high doses of BFA, although the presentation of epitopes 25-43 and 34-45 was inhibited to a lesser extent at concentrations lower than 30/~M BFA.
Out of the five Ak-restricted HEL epitopes studied here, only the presentation of the epitope 46-61 was enhanced in the presence of an invariant chain. This may indicate that the Ii-mediated targeting of the class II/Ii complex to a prelysosomal compartment (4) is responsible for the selective enhancement in the presentation of HEL(46-61). The presentation of this epitope, and of 116-129, was clearly more sensitive to chloroquine than the epitopes 25-43 and 34-45. In line with these results are observations showing that the chloroquine-sensitive environment of lysosomes is required for the initial reduction of disulfide bonds in HEL, and subsequent presentation of the epitope 46-61 (25, 26). The HEL epitopes 34-45 and 25-43 are virtually insensitive to chloroquine, suggesting processing in early endocytic compartments, where protein breakdown may be less dependent on acidic pH, or processing by endoproteinases relatively resistant to increased pH.
Alternatively, the loading of peptides onto class II molecules, rather than their deavage, could be differentially influenced by chloroquine. This would be consistent with the observation that the binding of peptide 34-45 to fixed A kexpressing cells is unchanged between pH 5.0 to pH 7.4, whereas the binding of peptide 46-61 shows an optimum at pH 5.5 (27). Utilizing purified A k molecules, Sette et al., found a binding optimum for HEL(46-61) at pH 4.5 (28) .
In RKK cells, the presentation of peptide 46-61 was significantly more sensitive to BFA treatment than the presentation of the peptides 25-43 and 34-45. In line with previous observations (24, 29) this may imply that the peptide 46-61 binds to A k in an endosomal subcompartment fed with newly synthesized class II molecules which are retained in the ER in the presence of BFA. In contrast, the peptides 25-43 and 34-45 seem to have access to a pool of preexisting class II molecules that may arise from internalization of unloaded molecules from the surface. In RKKI cells the presentation of the three HEL peptides, 25-43, 34-45, and 46-61, was dearly sensitive to BFA, indicating presentation by newly synthesized class II molecules.
In conclusion, it appears that the augmenting effect of Ii is actually epitope specific rather than simply antigen specific (9, 10, 14) . In addition, distinct pathways of presentation for different HEL epitopes exist. The epitope 46-61 is exclusively or predominantly bound by newly synthesized class II molecules and its presentation is highly chloroquine sensitive, whereas in the absence of Ii the epitopes 25-43 and 34-45 can be presented by a pool of preexisting class II or, in the presence of Ii, also by newly synthesized class II molecules. The precise rules controlling preferential presentation of particular epitopes from the same protein antigen by different pathways remain to be explored. This work was supported by DFG grant Mo 389/2-1.
